LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION
Classification, modes of action and clinical effects of calcium channel blockers are presented. Advantages of the third generation of dihydropyridine calcium channel blockers are considered. Clinical pharmacology, studies on the efficacy, safety and prevention of hypertensive complications with lerc...
Saved in:
Main Authors: | , , |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2015-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_c36845fac9ee4c8881cc50a6a0c6baf6 | ||
042 | |a dc | ||
100 | 1 | 0 | |a O. D. Ostroumova |e author |
700 | 1 | 0 | |a M. L. Maksimov |e author |
700 | 1 | 0 | |a I. I. Kopchenov |e author |
245 | 0 | 0 | |a LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION |
260 | |b Столичная издательская компания, |c 2015-09-01T00:00:00Z. | ||
500 | |a 1819-6446 | ||
500 | |a 2225-3653 | ||
500 | |a 10.20996/1819-6446-2013-9-1-79-85 | ||
520 | |a Classification, modes of action and clinical effects of calcium channel blockers are presented. Advantages of the third generation of dihydropyridine calcium channel blockers are considered. Clinical pharmacology, studies on the efficacy, safety and prevention of hypertensive complications with lercanidipine are detailed. | ||
546 | |a EN | ||
546 | |a RU | ||
690 | |a arterial hypertension | ||
690 | |a antihypertensive therapy | ||
690 | |a calcium antagonists | ||
690 | |a lercanidipine | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
690 | |a Diseases of the circulatory (Cardiovascular) system | ||
690 | |a RC666-701 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Рациональная фармакотерапия в кардиологии, Vol 9, Iss 1, Pp 79-85 (2015) | |
787 | 0 | |n https://www.rpcardio.online/jour/article/view/77 | |
787 | 0 | |n https://doaj.org/toc/1819-6446 | |
787 | 0 | |n https://doaj.org/toc/2225-3653 | |
856 | 4 | 1 | |u https://doaj.org/article/c36845fac9ee4c8881cc50a6a0c6baf6 |z Connect to this object online. |